GL1X · GenesisL1 explorer

Research workbench

Ly-COV481 neutralizing antibody against SARS-cov-2

Analyse Ly-COV481 neutralizing antibody against SARS-cov-2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7KMI
Type
protein
Length
627 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ly-COV481 Fab heavy chain; Ly-COV481 Fab light chain; Spike protein S1
UniProt
P0DTC2
Ligands
NAG
Pockets
6 · best druggability 0.68

Structure

x-ray diffraction · 3 distinct chains · 11% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALy-COV481 Fab heavy chainprotein2188% helix, 52% strand—
BLy-COV481 Fab light chainprotein2136% helix, 53% strand—
CSpike protein S1protein19618% helix, 30% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains C
  • GOL · Glycerol · additive · 2 copies · chains B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1530.680.9720empty
23930.550.7453empty
31090.540.8319empty
42350.500.7533empty
5990.340.7319empty

Interfaces

3 interfaces between chains.

  • A–B · 1849 Ų buried · 18 hydrogen bonds · protein-protein
  • A–C · 679 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 505 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 9 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7KMI · LY-CoV481 neutralizing antibody against SARS-CoV-2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.